| Utilization of FibroScan in clinical practice A Bonder, N Afdhal Current gastroenterology reports 16, 1-7, 2014 | 166 | 2014 |
| The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis EB Tapper, N Sengupta, A Bonder The American journal of medicine 128 (12), 1314-1321, 2015 | 151 | 2015 |
| The diagnostic approach and current management of chylous ascites B Lizaola, A Bonder, HD Trivedi, EB Tapper, A Cardenas Alimentary pharmacology & therapeutics 46 (9), 816-824, 2017 | 148 | 2017 |
| A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA JM Schattenberg, A Pares, KV Kowdley, MA Heneghan, S Caldwell, ... Journal of hepatology 74 (6), 1344-1354, 2021 | 117 | 2021 |
| Liver fibrosis and inflammation. A review DK Stalnikowitz, AB Weissbrod Annals of hepatology 2 (4), 159-163, 2003 | 106 | 2003 |
| Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population NE Castillo, RR Vanga, TG Theethira, A Rubio-Tapia, JA Murray, ... Official journal of the American College of Gastroenterology| ACG 110 (8 …, 2015 | 87 | 2015 |
| Prevalence of primary biliary cirrhosis–autoimmune hepatitis overlap syndrome A Bonder, A Retana, DM Winston, J Leung, MM Kaplan Clinical Gastroenterology and Hepatology 9 (7), 609-612, 2011 | 73 | 2011 |
| Evaluation of liver lesions A Bonder, N Afdhal Clinics in liver disease 16 (2), 271-283, 2012 | 72 | 2012 |
| Hemostasis, bleeding and thrombosis in liver disease B Flores, HD Trivedi, SC Robson, A Bonder Journal of translational science 3 (3), 2017 | 69 | 2017 |
| Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid MM Kaplan, A Bonder, R Ruthazer, PAL Bonis Digestive diseases and sciences 55, 3207-3217, 2010 | 55 | 2010 |
| Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome C Efe, M Torgutalp, I Henriksson, F Alalkim, E Lytvyak, H Trivedi, F Eren, ... Journal of gastroenterology and hepatology 36 (4), 936-942, 2021 | 53 | 2021 |
| Bone health in patients with liver diseases CJ Danford, HD Trivedi, A Bonder Journal of clinical densitometry 23 (2), 212-222, 2020 | 53 | 2020 |
| Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis C Corpechot, F Carrat, F Gaouar, F Chau, G Hirschfield, A Gulamhusein, ... Journal of hepatology 77 (6), 1545-1553, 2022 | 52 | 2022 |
| Osteoporosis in primary biliary cholangitis CJ Danford, HD Trivedi, K Papamichael, EB Tapper, A Bonder World Journal of Gastroenterology 24 (31), 3513, 2018 | 49 | 2018 |
| Validation of risk scoring systems in ursodeoxycholic acid–treated patients with primary biliary cholangitis C Efe, K Tascilar, I Henriksson, E Lytvyak, F Alalkim, H Trivedi, F Eren, ... Official journal of the American College of Gastroenterology| ACG 114 (7 …, 2019 | 48 | 2019 |
| Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis BL Freedman, CJ Danford, V Patwardhan, A Bonder Journal of clinical medicine 9 (5), 1449, 2020 | 46 | 2020 |
| Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis M Vuerich, R Harshe, LA Frank, S Mukherjee, B Gromova, E Csizmadia, ... Journal of hepatology 74 (1), 48-57, 2021 | 44 | 2021 |
| Contemporary assessment of hepatic fibrosis A Bonder, EB Tapper, NH Afdhal Clinics in liver disease 19 (1), 123-134, 2015 | 42 | 2015 |
| Management of pruritus in primary biliary cholangitis: a narrative review HD Trivedi, B Lizaola, EB Tapper, A Bonder The American Journal of Medicine 130 (6), 744. e1-744. e7, 2017 | 40 | 2017 |
| Treatment cessation in noncirrhotic, e‐antigen negative chronic hepatitis B is safe and effective following prolonged anti‐viral suppression with nucleosides/nucleotides VR Patwardhan, N Sengupta, A Bonder, D Lau, NH Afdhal Alimentary pharmacology & therapeutics 40 (7), 804-810, 2014 | 39 | 2014 |
Vilas PatwardhanAssistant Professor of Medicine - Harvard Medical School在 bidmc.harvard.edu 的电子邮件经过验证
